European journal of ophthalmology
Functional and Structural Impact of Switching to Bevacizumab in neovascular-AMD Patients Treated with Aflibercept or Ranibizumab.
Alessio Muzi, Giulia Gregori, Lorenzo Mangoni, Veronica Mogetta, Jay Chhablani, Daniela Fruttini, Tito Fiore, Clara Rizzo, Cesare Mariotti, Marco Lupidi
Published: 202510.1177/11206721251409237
Abstract
PurposeTo evaluate the functional and structural outcomes in patients with neovascular age-related macular degeneration (nAMD) switched from ranibizumab or aflibercept to bevacizumab.MethodsThis retrospective study included 197 eyes of 192 patients (…
Preview only. Read the full abstract at the source